Mucosal Vaccination with <i>Lactococcus lactis</i>-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B <i>Streptococcus</i> in a Murine Model

Mucosal Vaccination with <i>Lactococcus lactis</i>-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B <i>Streptococcus</i> in a Murine Model

Group B <i>Streptococcus</i> (GBS) is the primary etiological agent of sepsis and meningitis in newborns and is associated with premature birth and stillbirth. The development of a licensed vaccine is one of the pending challenges for the World Health Organization. Previously, we showed...

Full description

Bibliographic Details
Main Authors: Diego A. Diaz-Dinamarca, Carlos Hernandez, Daniel F. Escobar, Daniel A. Soto, Guillermo A. Muñoz, Jesús F. Badilla, Ricardo A. Manzo, Flavio Carrión, Alexis M. Kalergis, Abel E. Vasquez
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Vaccines
Subjects:
group b streptococcus
mucosal vaccine
surface immunogenic protein
cellular immune response
humoral immune response
Online Access:https://www.mdpi.com/2076-393X/8/2/146

Internet

https://www.mdpi.com/2076-393X/8/2/146

Similar Items